Drug firm Natco Pharma today reported a 93.27 per cent rise in its consolidated net profit to Rs 181.1 crore for the quarter ended June 30 mainly on account of robust sales.
Consolidated total revenue of the company stood at Rs 574.5 crore for the quarter under consideration. It was Rs 448.7 crore in the corresponding period of the previous fiscal.
The company's board of directors have approved an interim dividend of Rs 1.50 per equity share of Rs 2 each, Natco Pharma said.
Shares of Natco Pharma today closed 0.06 per cent lower at Rs 812.85 per scrip on the BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)